Global regulatory harmonization for medical devices appears to be the theme to start the year. Read Emergo by UL’s 2024 medical device regulatory insights.
To continue our KIMES 2024 medical device regulation coverage, we discuss our presentation on European Regulation 2023/607.
At Korea’s KIMES 2024 we revealed regulatory tips, including an overview of the current U.S. eSTAR template for submitting 510(k)s or De Novo reclassification applications to the U.S. FDA.
The Australian Therapeutic Goods Administration (TGA) communicated an update March 26, 2024 on its Recall Reforms Program for medical devices.
The recitals of the Medical Devices Regulation (MDR) (EU) 2017/745 explain the importance of aligning clinical investigation provisions with ISO 14155.
The World Health Organization announced a call for submissions (March 20, 2024) for its fifth Essential Devices List (EDL); an evidence-based health policy document analogous to the WHO Essential Medicines List.
Learn more about the steps in the MDSAP transition process.
As Brazil’s ANVISA RDC 848/2024 becomes mandatory in 180 days, medical device and IVD manufacturers must assess the additional compliance requirements and update their Essential Safety and Performance Requirement checklists.
Schedule a meeting to learn more about how we can support you in getting to market faster.
In our third article in a series, we take a look at how manufacturers can submit MDSAP Certificates in Place of on-site K-GMP audits.